Retrieve available abstracts of 14 articles: HTML format
Single Articles
August 2025
PHAM TP, Pham HT, Doan PM, Hoang NA, et al Structural equation modelling of nucleotide polymorphisms and pharmacokinetics in
direct oral anticoagulant use for stroke and embolism prevention in atrial
fibrillation.
Eur J Pharmacol. 2025;1005:178049. PubMedAbstract available
July 2025
CHEN J, Zhang W, Li Z, Hu T, et al Pyridostigmine Improves Post-Resuscitation Myocardial Dysfunction in a Rat Model
of Ventricular Fibrillation-Induced Cardiac Arrest and Resuscitation.
Eur J Pharmacol. 2025 Jul 10:177917. doi: 10.1016/j.ejphar.2025.177917. PubMedAbstract available
June 2025
LI Y, Sun J, Li X, Yu W, et al Donepezil-induced degradation of hERG potassium channel via lysosomal pathway is
exacerbated by hypoxia.
Eur J Pharmacol. 2025;996:177549. PubMedAbstract available
April 2025
LI TL, Zhu NN, Zhao MX, Sun J, et al Omentin-1 attenuates atrial fibrillation via Src/PI3K/Akt signaling-mediated
anti-fibrotic effects in cardiac fibroblasts.
Eur J Pharmacol. 2025;996:177588. PubMedAbstract available
March 2025
LIU GX, Diao F, Lu G, Zheng Q, et al Alectinib causes sinus bradycardia by suppressing L-type calcium current in sinus
node.
Eur J Pharmacol. 2025 Mar 19:177527. doi: 10.1016/j.ejphar.2025.177527. PubMedAbstract available
January 2025
PAN QM, Bi FF, Jing ZH, Cao M, et al A New target of ischemic ventricular arrhythmias-ITFG2.
Eur J Pharmacol. 2025 Jan 24:177301. doi: 10.1016/j.ejphar.2025.177301. PubMedAbstract available
August 2024
HU HJ, Wang XH, Zhang ZZ, Ou Y, et al SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced
atrial fibrosis and vulnerability to atrial fibrillation via suppression of the
TGF-beta1/Smad2/3 signalling pathway.
Eur J Pharmacol. 2024 Aug 19:176900. doi: 10.1016/j.ejphar.2024.176900. PubMedAbstract available
ZHANG Y, Li R, Jiang H, Hou Y, et al Salidroside modulates repolarization through stimulating Kv2.1 in rats.
Eur J Pharmacol. 2024;977:176741. PubMedAbstract available
LIU CM, Lin FJ, Chhay C, Chen YC, et al Ibrutinib, a Bruton's tyrosine kinase inhibitor, regulates ventricular
electromechanical activities and enhances arrhythmogenesis.
Eur J Pharmacol. 2024;977:176675. PubMedAbstract available
June 2024
ZHAN G, Wang X, Wang X, Li J, et al Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin
II-induced atrial fibrillation by regulating atrial electrical and structural
remodeling.
Eur J Pharmacol. 2024;978:176712. PubMedAbstract available
SONG S, Yuan J, Fang G, Li Y, et al BRD4 as a Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation.
Eur J Pharmacol. 2024 Jun 5:176714. doi: 10.1016/j.ejphar.2024.176714. PubMedAbstract available
November 2023
LI F, Qian LL, Wu LD, Zhang ZY, et al Glucose fluctuations aggravated the late sodium current induced ventricular
arrhythmias via the activation of ROS/CaMKII pathway.
Eur J Pharmacol. 2023 Nov 6:176167. doi: 10.1016/j.ejphar.2023.176167. PubMedAbstract available
YI Y, Tianxin Y, Zhangchi L, Cui Z, et al Pinocembrin attenuates susceptibility to atrial fibrillation in rats with
pulmonary arterial hypertension.
Eur J Pharmacol. 2023;960:176169. PubMedAbstract available
October 2023
DE LIMA CONCEICAO MR, Teixeira-Fonseca JL, Marques LP, Souza DS, et al Interaction of the antiarrhythmic drug Amiodarone with the sodium channel
Na(v)1.5 depends on the extracellular pH.
Eur J Pharmacol. 2023 Oct 17:176127. doi: 10.1016/j.ejphar.2023.176127. PubMedAbstract available